Dennis Thompson, DO
Adult Medicine · Cleveland, TNNPI 1326151655
Payments from drug & device makers
Across 606 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$960
- Lilly USA, LLC$911
- AbbVie$788
- Pfizer$695
- Bayer$478
- plus $4K from 40 others
What the payments were for
- Food & beverage$10,031100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$10,036 in reported general payments places this provider in the 90th percentile of 22 adult medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 63 | $159,653 |
| JardianceEmpagliflozin | 146 | $159,019 |
| OzempicSemaglutide | 77 | $98,878 |
| EliquisApixaban | 86 | $86,737 |
| Tresiba Flextouch U-200Insulin Degludec | 45 | $66,959 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 46 | $51,973 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 29 | $48,125 |
| FarxigaDapagliflozin Propanediol | 46 | $44,159 |
| XareltoRivaroxaban | 41 | $41,886 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $25,129 |
| TrulicityDulaglutide | 19 | $20,898 |
| MyrbetriqMirabegron | 17 | $14,032 |
| Novolog FlexpenInsulin Aspart | 23 | $13,204 |
| SymbicortBudesonide/Formoterol Fumarate | 26 | $8,058 |
| VascepaIcosapent Ethyl | 15 | $7,450 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskXultophy 100-3.6, Ozempic | $1,850 | $258,531140 claims |
| Boehringer IngelheimJardiance | $301 | $159,019146 claims |
| PfizerEliquis | $695 | $86,73786 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $960 | $77,34699 claims |
| GSKTrelegy Ellipta | $126 | $51,97346 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $286 | $48,12529 claims |
| Johnson & JohnsonXarelto | $214 | $41,88641 claims |
| Lilly USA, LLCTrulicity | $911 | $20,89819 claims |
| Astellas Pharma US IncMyrbetriq | $132 | $14,03217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 22 adult medicine providers in Tennessee.
Other adult medicine in Cleveland
- Paul BoeremaCleveland$11K
- William HaysCleveland$10K
- Allan ChastainCleveland$4K
- Michael KelloggGallatin$19K
- Cynthia ShafferOoltewah$5K
- John LeeMurfreesboro$4K
- Bojidar DolaptchievNewport$2K
- John SherrillBristol$1K
- Jung ParkDunlap$889
- Jill WallnerCrossville$686
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.